Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
FDA+ channel feed
Organon shelves contraceptive with 'natural' estrogen
Last year
Pharma
Stakeholders brace for bumps in rare pediatric disease PRV reauthorization
Last year
Pharma
Takeda wins long-awaited US approval for first oral drug for eosinophilic esophagitis
Last year
Pharma
FDA addresses expanded use of data monitoring committees in draft guidance
Last year
Pharma
FDA finalizes rule on using master files in biologics applications
Last year
Pharma
US and EU regulators begin offering parallel scientific advice to generic drugmakers
Last year
After 'misleading' information delays FDA inspection, Chinese API manufacturer hit with an OAI
Last year
Manufacturing
House passes ban on use of QALYs in federal health programs
Last year
Pharma
AstraZeneca CEO calls opening IRA drug price offer 'relatively encouraging' in first characterization of talks
Last year
Pharma
Catalent’s Indiana site closes out three Form 483s in past two years
Last year
Manufacturing
EMA seeks to ease the regulatory burden on biosimilar developers, following push by FDA
Last year
House committee advances another PBM reform bill that would ban spread pricing
Last year
Pharma
Lawmakers hold FDA foreign inspection practices under microscope at hearing without agency attendance
Last year
Pharma
Manufacturing
Behind generic drug shortages, House committee points to lackluster manufacturing and high prices
Last year
Manufacturing
Will an upcoming Senate hearing help lower drug prices? It depends who you ask
Last year
Pharma
Vertex unveils cystic fibrosis data, talks of using priority review voucher
Last year
Pharma
Vanda takes issue with FDA's relay of deficiencies for new Hetlioz indication
Last year
Pharma
Makers of blockbuster weight loss drugs are using 'patent thickets' to protect products, Harvard study claims
Last year
Pharma
FDA to modernize drug surveillance internally with use of AI
Last year
AI
American Bar Association says lower court was 'ill-equipped' to restrict abortion pill use
Last year
Pharma
Law
Draft 340B reforms include user fees, clarity around contract pharmacies
Last year
Pharma
Law
Former FDA commissioners urge SCOTUS to preserve agency’s regulations of abortion pill
Last year
Pharma
Law
AGC Biologics hit with 483 for poor discrepancy investigation practices, quality control issues at Washington site
Last year
Pharma
Manufacturing
'Systemic' changes coming to advisory committee process, FDA commissioner says
Last year
First page
Previous page
32
33
34
35
36
37
38
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit